3-Chlorotyrosine as a marker of protein damage by myeloperoxidase in tracheal aspirates from preterm infants: Association with adverse respiratory outcome

Pediatric Research

Volumn 53, Issue 3, 2003, Pages 455-462

  Hendrikje Buss, I ^a   Senthilmohan, Revathy ^a   Darlow, Brian A ^a   Mogridge, Nina ^a   Kettle, Anthony J ^a   Winterbourn, Christine C ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

3 CHLOROTYROSINE; BIOLOGICAL MARKER; HYPOCHLOROUS ACID; MYELOPEROXIDASE; OXIDIZING AGENT; SELENIUM; SUPEROXIDE DISMUTASE; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; ASPIRATION; CHRONIC LUNG DISEASE; DISEASE COURSE; HUMAN; HUMAN TISSUE; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; NEUTROPHIL; NEWBORN; PATHOGENESIS; PREMATURITY; PRIORITY JOURNAL; PROTEIN DEFECT;

BIOLOGICAL MARKERS; CHRONIC DISEASE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; NEUTROPHILS; OXIDATIVE STRESS; PEROXIDASE; RESPIRATORY DISTRESS SYNDROME, NEWBORN; TRACHEA; TYROSINE; UREAPLASMA INFECTIONS; UREAPLASMA UREALYTICUM;

EID: 0037372157     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000050655.25689.CE     Document Type: Article

References (49)

1. Pitkänen OM, Hallman M, Andersson SM 1990 Correlation of free oxygen radical-induced lipid peroxidation with outcome in very low birth weight infants. J Pediatr 116:760-764
2. Varsila E, Pitkänen OM, Hallman M, Andersson S 1994 Immaturity-dependent free radical activity in premature infants. Pediatr Res 36:55-59
3. Wispe JR, Bell EF, Roberts RJ 1985 Assessment of lipid peroxidation in newborn infants and rabbits by measurements of expired ethane and pentane: influence of parenteral lipid infusion. Pediatr Res 19:374-379
4. Buss IH, Darlow BA, Winterbourn CC 2000 Elevated protein carbonyls, lipid peroxidation products and myeloperoxidase in tracheal aspirates from premature infants. Pediatr Res 47:640-645
5. Gladstone IM, Levine RL 1994 Oxidation of proteins in neonatal lungs. Pediatrics 93:764-768
6. Schock BC, Sweet DG, Halliday HL, Young IS, Ennis M 2001 Oxidative stress in lavage fluid of preterm infants at risk of chronic lung disease. Am J Physiol 281:L1386-L1391
7. Varsila E, Pesonen E, Andersson A 1995 Early protein oxidation in the neonatal lung is related to development of chronic lung disease. Acta Paediatr 84:1296-1299
8. Saugstad OD 2001 Chronic lung disease: oxygen dogma revisited. Acta Paediatr 90:113-115
9. Winterbourn CC, Chan TP, Buss IH, Inder TE, Mogridge N, Darlow BA 2000 Protein carbonyls and lipid peroxidation products as oxidation markers in preterm infant plasma: associations with chronic lung disease and retinopathy and effect of selenium supplementation. Pediatr Res 48:84-90
10. Zimmerman JJ 1995 Bronchoalveolar inflammatory pathophysiology of bronchopulmonary dysplasia. Clin Perinatol 22:429-457
11. Watterberg KL, Demers LM, Scott SM, Murphy S 1996 Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 97:210-215
12. Speer CP 1999 Inflammatory mechanisms in neonatal chronic lung disease. Eur J Pediatr 158(suppl 1):S18-S22
13. Groneck P, Gotze-Speer B, Opperman M, Eiffert H, Speer CP 1994 Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high risk preterm neonates. Pediatrics 93:712-718
14. De Dooy JJ, Mahieu LM, Van Bever HP 2001 The role of inflammation in the development of chronic lung disease in neonates. Eur J Pediatr 160:457-463
15. Merritt TA, Stuard ID, Puccia J, Wood B, Edwards DK, Finkelstein J, Shirpiro DL 1981 Newborn tracheal aspirate cytology: classification during respiratory distress syndrome and bronchopulmonary dysplasia. J Pediatr 98:949-956
16. Jackson TC, Chi EY, Wilson CB 1987 Sequence of inflammatory cell migration into lung during recovery from hyaline membrane disease in premature newborn monkeys. Am Rev Respir Dis 135:937-940
17. Ogden BE, Murphy SA, Saunders GC, Pathak D, Johnson JD 1984 Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis 130:817-821
18. Kettle AJ, Winterbourn CC 1997 Myeloperoxidase: a key regulator of neutrophil oxidant production. Redox Rep 3:3-15
19. Pullar JM, Vissers MCM, Winterbourn CC 2000 Living with a killer: the effects of hypochlorous acid on mammalian cells. IUBMB Life 50:259-266
20. Winterbourn CC, Kettle AJ 2000 Biomarkers of myeloperoxidase-derived hypochlorous acid. Free Radic Biol Med 29:403-409
21. Stadtman ER 1990 Metal ion catalysed oxidation of proteins: biochemical mechanism and biological consequences. Free Radic Biol Med 9:315-325
22. Chapman ALP, Senthilmohan R, Winterbourn CC, Kettle AJ 2000 Comparison of mono and dichlorinated tyrosines with carbonyls for detection of hypochlorous acid-modified proteins. Arch Biochem Biophys 377:95-100
23. Winterbourn CC, Buss IH 1999 Protein carbonyl measurement by enzyme-linked immunosorbent assay. Methods Enzymol 300:106-111
24. Kettle AJ 1996 Neutrophils convert tyrosyl residues in albumin to chlorotyrosine. FEBS Lett 379:103-106
25. Hazen SL, Heinecke JW 1997 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest 99:2075-2081
26. Hazen SL, Crowley JR, Mueller DM, Heinecke JW 1997 Mass spectrometric quantification of 3-chlorotyrosine in human tissues with attomole sensitivity: a sensitive and specific marker for myeloperoxidase-catalyzed chlorination at sites of inflammation. Free Radic Biol Med 23:909-916
27. Chapman ALP, Hampton MB, Senthilmohan R, Winterbourn CC, Kettle AJ 2002 Chlorination of bacterial and neutrophil proteins during phagocytosis and killing of Staphylococcus aureus. J Biol Chem 277:9757-9762
28. Gaut JP, Yeh GC, Tran HD, Byun J, Henderson JP, Richter GM, Brennan ML, Lusis AJ, Belaaouaj A, Hotchkiss RS, Heinecke JW 2001 1966 Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proc Natl Acad Sci U S A 98:11961-11966
29. Darlow BA, Winterbourn CC, Inder TE, Graham PJ, Harding JE, Weston PJ, Austin NC, Elder DE, Mogridge N, Buss IH, Sluis KB 2000 The effect of selenium supplementation on outcome in very low birthweight infants: a randomised controlled trial. J Pediatr 136:473-480
30. Suresh GK, Davis JM, Soll RF 2001 Superoxide dismutase for preventing chronic lung disease in mechanically ventilated preterm infants. Cochrane Database Syst Rev 1:CD001968
31. Jankov RP, Negus A, Tanswell AK 2001 Antioxidants as therapy in the newborn: some words of caution. Pediatr Res 50:681-687
32. Darlow BA, Sluis KB, Inder TE, Winterbourn CC 1997 Endotracheal suctioning of the neonate: balancing clinical and research needs. Pediatr Pulmonol 23:217-221
33. Bozeman PM, Learn DB, Thomas EL 1990 Assay of the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase. J Immunol Methods 126:125-133
34. Thomas EL, Jefferson MM, Joyner RE, Cook GS, King CC 1994 Leukocyte myeloperoxidase and salivary lactoperoxidase: identification and quantitation in human mixed saliva. J Dent Res 73:544-555
35. Frank L, Sosenko IRS 1987 Development of lung antioxidant enzyme system in late gestation: possible implications for the prematurely born infant. J Pediatr 110:9-14
36. Welty SE, Smith CV 2001 Rationale for antioxidant therapy in premature infants to prevent bronchopulmonary dysplasia. Nutr Rev 59:10-17
37. Kelly FJ 1993 Free radical disorders of preterm infants. Br Med Bull 49:668-678
38. American Academy of Pediatrics and Canadian Paediatric Society 2002 Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 109:330-338
39. Vigneswaran R 2000 Infection and preterm birth: evidence of a common causal relationship with bronchopulmonary dysplasia and cerebral palsy. J Paediatr Child Health 36:293-296
40. Abele-Horn M, Genzel-Boroviczeny O, Uhlig T, Zimmermann A, Peters J, Scholz M 1998 Ureaplasma urealyticum colonization and bronchopulmonary dysplasia: a comparative prospective multicentre study. Eur J Pediatr 157:1004-1011
41. Van Marter LJ, Dammann O, Allred EN, Leviton A, Pagano M, Moore M, Martin C 2002 Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr 140:171-176
42. Domigan NM, Charlton TS, Duncan MW, Winterbourn CC, Kettle AJ 1995 Chlorination of tyrosyl residues in peptides by myeloperoxidase and human neutrophils. J Biol Chem 270:16542-16548
43. Podrez EA, Abu-Soud HM, Hazen SL 2000 Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med 28:1717-1725
44. Lamb NJ, Gutteridge JM, Baker C, Evans TW, Quinlan GJ 1999 Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: evidence for neutrophil-mediated hydroxylation, nitration, and chlorination. Crit Care Med 27:1738-1744
45. MacPherson JC, Comhair SA, Erzurum SC, Klein DF, Lipscomb MF, Kavuru MS, Samoszuk MK, Hazen SL 2001 Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species. J Immunol 166:5763-5772
46. De Andrade JA, Crow JP, Viera L, Bruce AC, Randall YK, McGiffin DC, Zorn GL, Zhu S, Matalon S, Jackson RM 2000 Protein nitration, metabolites of reactive nitrogen species, and inflammation in lung allografts. Am J Respir Crit Care Med 161:2035-2042
47. van der Vliet A, Nguyen MN, Shigenaga MK, Eiserich JP, Marelich GP, Cross CE 2000 Myeloperoxidase and protein oxidation in cystic fibrosis. Am J Physiol 279:L537-L546
48. Gaut JP, Byun J, Tran HD, Heinecke JW 2002 Artifact-free quantification of free 3-chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine in human plasma by electron capture-negative chemical ionization gas chromatography mass spectrometry and liquid chromatographyelectrospray ionization tandem mass spectrometry. Anal Biochem 300:252-259
49. Inder TE, Mocatta T, Darlow BA, Spencer C, Senthilmohan R, Winterbourn CC, Volpe JJ 2002 Elevation of oxidative injury markers in the CNS with periventricular leukomalacia in a premature infant with meningitis. J Pediatr 140:617-621